Cited by 475Cannabis and Cannabinoid ResearchMedicinal Plant Extracts EffectsPsychedelics and Drug Studies

The DOI matches its Crossref record; 135 of the 135 references it cites were found in a registry or an index.

Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders

Open access

Campos, Alline Cristina, Moreira, Fabricio Araújo, Gomes, Felipe Villela, Del Bel, Elaine Aparecida, Guimarães, Francisco Silveira·2012·Philosophical Transactions of the Royal Society B: Biological Sciences

DOI 10.1098/rstb.2011.0389PMC PMC3481531

Open this paper in CoChat — free account

Abstract

Cannabidiol (CBD) is a major phytocannabinoid present in the Cannabis sativa plant. It lacks the psychotomimetic and other psychotropic effects that the main plant compound Δ(9)-tetrahydrocannabinol (THC) being able, on the contrary, to antagonize these effects. This property, together with its safety profile, was an initial stimulus for the investigation of CBD pharmacological properties. It is now clear that CBD has therapeutic potential over a wide range of non-psychiatric and psychiatric disorders such as anxiety, depression and psychosis. Although the pharmacological effects of CBD in different biological systems have been extensively investigated by in vitro studies, the mechanisms responsible for its therapeutic potential are still not clear. Here, we review recent in vivo studies indicating that these mechanisms are not unitary but rather depend on the behavioural response being measured. Acute anxiolytic and antidepressant-like effects seem to rely mainly on facilitation of 5-HT1A-mediated neurotransmission in key brain areas related to defensive responses, including the dorsal periaqueductal grey, bed nucleus of the stria terminalis and medial prefrontal cortex. Other effects, such as anti-compulsive, increased extinction and impaired reconsolidation of aversive memories, and facilitation of adult hippocampal neurogenesis could depend on potentiation of anandamide-mediated neurotransmission. Finally, activation of TRPV1 channels may help us to explain the antipsychotic effect and the bell-shaped dose-response curves commonly observed with CBD. Considering its safety profile and wide range of therapeutic potential, however, further studies are needed to investigate the involvement of other possible mechanisms (e.g. inhibition of adenosine uptake, inverse agonism at CB2 receptor, CB1 receptor antagonism, GPR55 antagonism, PPARγ receptors agonism, intracellular (Ca(2+)) increase, etc.), on CBD behavioural effects.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1098/rstb.2011.0389

Cites

135 of 135 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants
Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., et al. (2003) · Science · doi:10.1126/science.1083328 · Cited by 4,321
The Cloned Capsaicin Receptor Integrates Multiple Pain-Producing Stimuli
Tominaga, M., Caterina, M. J., Malmberg, A. B., Rosen, T. A., Gilbert, H., Skinner, K., Raumann, B. E., Basbaum, A. I., & Julius, D. J. (1998) · Neuron · doi:10.1016/s0896-6273(00)80564-4 · Cited by 3,086
Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish
Gaoni, Y., & Mechoulam, R. (1964) · Journal of the American Chemical Society · doi:10.1021/ja01062a046 · Cited by 2,389
Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide
Zygmunt, P. M., Petersson, J., Andersson, D. A., Chuang, H.-H., Sørgård, M., Di Marzo, V., Julius, D., & Högestätt, E. D. (1999) · Nature · doi:10.1038/22761 · Cited by 2,142
The molecular logic of endocannabinoid signalling
Piomelli, D. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1247 · Cited by 1,957
The endogenous cannabinoid system controls extinction of aversive memories
Marsicano, G., Wotjak, C. T., Azad, S. C., Bisogno, T., Rammes, G., Cascio, M. G., Hermann, H., Tang, J., Hofmann, C., Zieglgänsberger, W., et al. (2002) · Nature · doi:10.1038/nature00839 · Cited by 1,728
Chronic Mild Stress (CMS) Revisited: Consistency and Behavioural-Neurobiological Concordance in the Effects of CMS
Willner, P. (2005) · Neuropsychobiology · doi:10.1159/000087097 · Cited by 1,605
The orphan receptor GPR55 is a novel cannabinoid receptor
Ryberg, E., Larsson, N., Sjögren, S., Hjorth, S., Hermansson, N., Leonova, J., Elebring, T., Nilsson, K., Drmota, T., & Greasley, P. J. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707460 · Cited by 1,568
Increasing adult hippocampal neurogenesis is sufficient to improve pattern separation
Sahay, A., Scobie, K. N., Hill, A. S., O'Carroll, C. M., Kheirbek, M. A., Burghardt, N. S., Fenton, A. A., Dranovsky, A., & Hen, R. (2011) · Nature · doi:10.1038/nature09817 · Cited by 1,567
Assessing antidepressant activity in rodents: recent developments and future needs
Cryan, J. F., Markou, A., & Lucki, I. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)02017-5 · Cited by 1,551

Flagged first, then by citations

Show all 135 references

Research works printed but not linked: 1

Campos A. C., 2011, Hippocampal proliferative processes are needed for behavioral effects of cannabidiol, Revista de Neurosciências, 19, 81

Sorted by citations

Items 101–200 of 474

Cannabidiol attenuates aggressive behavior induced by social isolation in mice: Involvement of 5-HT1A and CB1 receptors
dos Santos, A. H., Lisboa, S. F. D. S., Sonego, A. B., Coutinho, D., Gomes, F. V., & Guimarães, F. S. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.109637 · Cited by 71
Self-citation
Alterations in Gene and Protein Expression of Cannabinoid CB2 and GPR55 Receptors in the Dorsolateral Prefrontal Cortex of Suicide Victims
García‐Gutiérrez, M. S., Navarrete, F., Navarro, G., Reyes‐Resina, I., Franco, R., Lanciego, J. L., Giner, S., & Manzanares, J. (2018) · Neurotherapeutics · doi:10.1007/s13311-018-0610-y · Cited by 67
Antiapoptotic effects of cannabidiol in an experimental model of cognitive decline induced by brain iron overload
da Silva, V. K., de Freitas, B. S., Garcia, R. C. L., Monteiro, R. T., Hallak, J. E. C., Zuardi, A. W., Crippa, J. A. S., & Schröder, N. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0232-5 · Cited by 64
The Effectiveness of Cannabinoids in the Treatment of Posttraumatic Stress Disorder (PTSD): A Systematic Review
Hindocha, C., Cousijn, J., Rall, M., & Bloomfield, M. (2019) · Journal of Dual Diagnosis · doi:10.1080/15504263.2019.1652380 · Cited by 65
Cannabidiol Use for Fibromyalgia: Prevalence of Use and Perceptions of Effectiveness in a Large Online Survey
Boehnke, K. F., Gagnier, J. J., Matallana, L. K., & Williams, D. A. (2021) · Journal of Pain · doi:10.1016/j.jpain.2020.12.001 · Cited by 66
Intracellular Self-Assembly of Cyclic d -Luciferin Nanoparticles for Persistent Bioluminescence Imaging of Fatty Acid Amide Hydrolase
Yuan, Y., Wang, F., Tang, W., Ding, Z., Wang, L., Liang, L., Zheng, Z., Zhang, H., & Liang, G. (2016) · ACS Nano · doi:10.1021/acsnano.6b03412 · Cited by 62
Novel insights into mitochondrial molecular targets of iron-induced neurodegeneration: Reversal by cannabidiol
da Silva, V. K., de Freitas, B. S., Dornelles, V. C., Kist, L. W., Bogo, M. R., Silva, M. C., STRECK, E. L., Hallak, J. E. C., Zuardi, A. W., Crippa, J. A. S., et al. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.01.014 · Cited by 65
Cannabidiol attenuates haloperidol-induced catalepsy and c-Fos protein expression in the dorsolateral striatum via 5-HT1A receptors in mice
Sonego, A. B., Gomes, F. V., Bel, E. A. D., & Guimarães, F. S. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.04.042 · Cited by 62
Self-citation
A scoping review of the use of cannabidiol in psychiatric disorders
Kirkland, A. E., Fadus, M. C., Gruber, S. A., Gray, K. M., Wilens, T. E., & Squeglia, L. M. (2021) · Psychiatry Research · doi:10.1016/j.psychres.2021.114347 · Cited by 63
Fluorinated Cannabidiol Derivatives: Enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects
Breuer, A., Haj, C. G., Fogaça, M. V., Gomes, F. V., da Silva, N. R., Pedrazzi, J. F. C., Bel, E. A. D., Hallak, J. E. C., Crippa, J. A., Zuardi, A. W., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0158779 · Cited by 64
Self-citation
Phytocannabinoids in Neurological Diseases: Could They Restore a Physiological GABAergic Transmission?
Cifelli, P., Ruffolo, G., Felice, E. D., Alfano, V., van Vliet, E. A., Aronica, E., & Palma, E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030723 · Cited by 61
Cannabidiol for the treatment of crack-cocaine craving: an exploratory double-blind study
de Meneses-Gaya, C., Crippa, J. A. S., Hallak, J. E. C., Miguel, A. C., Laranjeira, R., Bressan, R. A., Zuardi, A. W., & Lacerda, A. L. T. (2020) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2020-1416 · Cited by 59
Cannabidiol attenuates seizures and EEG abnormalities in Angelman syndrome model mice
Gu, B., Zhu, M., Glass, M. R., Rougié, M., Nikolova, V. D., Moy, S. S., Carney, P. R., & Philpot, B. D. (2019) · Journal of Clinical Investigation · doi:10.1172/jci130419 · Cited by 59
The Divergent Effects of CDPPB and Cannabidiol on Fear Extinction and Anxiety in a Predator Scent Stress Model of PTSD in Rats
Shallcross, J., Hámor, P. U., Bechard, A. R., Romano, M., Knackstedt, L. A., & Schwendt, M. (2019) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2019.00091 · Cited by 61
Cannabidiol Oil for Decreasing Addictive Use of Marijuana: A Case Report.
Shannon, S. M., & Opila-Lehman, J. (2015) · PubMed Central · Cited by 56
The Endocannabinoid System and Anxiety
Lisboa, S. F. D. S., Gomes, F. V., Terzian, A. L. B., de Aguiar, D. C., Moreira, F. A., Resstel, L. B. M., & Guimarães, F. S. (2016) · Vitamins and hormones · doi:10.1016/bs.vh.2016.09.006 · Cited by 56
Self-citation
The Therapeutic Aspects of the Endocannabinoid System (ECS) for Cancer and their Development: From Nature to Laboratory
Khan, M. I., ska, A. A. S., Czarnecka, A. M., Król, M., Botta, B., & Szczylik, C. A. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666151211094901 · Cited by 57
The pharmacological reduction of hippocampal neurogenesis attenuates the protective effects of cannabidiol on cocaine voluntary intake
Luján, M. Á., Cantacorps, L., & Valverde, O. (2019) · Addiction Biology · doi:10.1111/adb.12778 · Cited by 54
Effects of Cannabidiol Supplementation on Skeletal Muscle Regeneration after Intensive Resistance Training
Isenmann, E., Veit, S., Starke, L., Flenker, U., & Diel, P. R. (2021) · Nutrients · doi:10.3390/nu13093028 · Cited by 54
Potential Use of Cannabinoids for the Treatment of Pancreatic Cancer
Sharafi, G., He, H. Z., & Nikfarjam, M. (2019) · Journal of Pancreatic Cancer · doi:10.1089/pancan.2018.0019 · Cited by 56
Therapeutic potential of cannabidiol (CBD) in anxiety disorders: A systematic review and meta-analysis.
Han, K., Wang, J.-Y., Wang, P.-Y., & Peng, Y.-C.-H. (2024) · Psychiatry research · doi:10.1016/j.psychres.2024.116049 · Cited by 54
A Randomized Controlled Trial of Topical Cannabidiol for the Treatment of Thumb Basal Joint Arthritis
Heineman, J. T., Forster, G. L., Stephens, K. L., Cottler, P. S., Timko, M. P., & DeGeorge, B. R. (2022) · The Journal Of Hand Surgery · doi:10.1016/j.jhsa.2022.03.002 · Cited by 52
Clinical outcome data of anxiety patients treated with cannabis-based medicinal products in the United Kingdom: a cohort study from the UK Medical Cannabis Registry
Rifkin-Zybutz, R. P., Erridge, S., Holvey, C., Coomber, R., Gaffney, J., Lawn, W., Barros, D. A. R., Bhoskar, U., Mwimba, G., Praveen, K., et al. (2023) · Psychopharmacology · doi:10.1007/s00213-023-06399-3 · Cited by 53
Effects of an acute cannabidiol treatment on cocaine self-administration and cue-induced cocaine seeking in male rats
Mahmud, A., Gallant, S., Sedki, F., D’Cunha, T. M., & Shalev, U. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116667706 · Cited by 51
The Cannabidiol Use in the Treatment of Epilepsy
Matos, R. L. A., Spinola, L. A., Barboza, L. L., Garcia, D. R., França, T. C. C., & Affonso, R. S. (2017) · Revista Virtual de Química · doi:10.21577/1984-6835.20170049 · Cited by 62
Cannabinoid CB1 Receptor Involvement in the Actions of CBD on Anxiety and Coping Behaviors in Mice
Austrich-Olivares, A., García‐Gutiérrez, M. S., Illescas, L., Gasparyan, A., & Manzanares, J. (2022) · Pharmaceuticals · doi:10.3390/ph15040473 · Cited by 52
Evidences for the Anti-panic Actions of Cannabidiol
Soares-Rachetti, V. D. P., & Campos, A. C. (2016) · Current Neuropharmacology · doi:10.2174/1570159x14666160509123955 · Cited by 52
Self-citation
Therapeutic potential and safety considerations for the clinical use of synthetic cannabinoids
Sholler, D. J., Huestis, M. A., Amendolara, B., Vandrey, R. G., & Cooper, Z. D. (2020) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2020.173059 · Cited by 50
Cannabinoids as therapeutics for PTSD
Sbarski, B., & Akirav, I. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107551 · Cited by 47
Emerging potential of cannabidiol in reversing proteinopathies
Dash, R., Ali, M. C., Jahan, I., Munni, Y. A., Mitra, S., Hannan, M. A., Timalsina, B., Oktaviani, D. F., Choi, H. J., & Moon, I. S. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101209 · Cited by 50
Cannabidiol induces antidepressant and anxiolytic‐like effects in experimental type-1 diabetic animals by multiple sites of action
Chaves, Y. C., Genaro, K., Crippa, J. A. S., da Cunha, J. M., & Zanoveli, J. M. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-020-00667-3 · Cited by 52
Potential role of cannabidiol in Parkinson’s disease by targeting the WNT/β-catenin pathway, oxidative stress and inflammation
Vallée, A., Vallée, J.-N., & Lecarpentier, Y. (2021) · Aging · doi:10.18632/aging.202951 · Cited by 47
Cannabidiol inhibits sucrose self‐administration by CB 1 and CB 2 receptor mechanisms in rodents
Bi, G., Galaj, E., He, Y., & Xi, Z. (2019) · Addiction Biology · doi:10.1111/adb.12783 · Cited by 48
The effect of a mixed cannabidiol and cannabidiolic acid based oil on client‐owned dogs with atopic dermatitis
Loewinger, M., Wakshlag, J. J., Bowden, D., Peters‐Kennedy, J., & Rosenberg, A. (2022) · Veterinary Dermatology · doi:10.1111/vde.13077 · Cited by 49
Cannabidiol for the Treatment of Brain Disorders: Therapeutic Potential and Routes of Administration
Yau, G. T. Y., Tai, W., Arnold, J. C., Chan, H., & Kwok, P. C. L. (2023) · Pharmaceutical Research · doi:10.1007/s11095-023-03469-1 · Cited by 48
Is there a role for cannabidiol in psychiatry?
Khoury, J. M., das Neves, M. D. C. L., Roque, M. A. V., Queiroz, D. A. D. B., de Freitas, A. A. C., de Fátima, Â., Moreira, F. A., & Garcia, F. D. (2017) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2017.1285049 · Cited by 45
Self-citation
MK-801-induced deficits in social recognition in rats
Deiana, S., Watanabe, A., Yamasaki, Y., Amada, N., Kikuchi, T., Stott, C. G., & Riedel, G. (2015) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000178 · Cited by 49
An observational study of safety and clinical outcome measures across patient groups in the United Kingdom Medical Cannabis Registry
Olsson, F., Erridge, S., Tait, J., Holvey, C., Coomber, R., Beri, S., Hoare, J. M., Khan, S. A., Weatherall, M. W., Platt, M. W., et al. (2023) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2023.2183841 · Cited by 44
Cannabinoid CB1 receptors in the dorsal hippocampus and prelimbic medial prefrontal cortex modulate anxiety-like behavior in rats: Additional evidence
Lisboa, S. F. D. S., Borges, A. A., Nejo, P., Fassini, A., Guimarães, F. S., & Resstel, L. B. M. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.01.005 · Cited by 44
Self-citation
Potential Effects of Cannabidiol as a Wake-Promoting Agent
Murillo‐Rodríguez, E., Sarro-Ramírez, A., Sanchez, D., Mijangos-Moreno, S., Tejeda-Padrón, A., Poot-Aké, A., Guzmán, K., Pacheco-Pantoja, E. L., & Arias-Carrión, Ó. (2014) · Current Neuropharmacology · doi:10.2174/1570159x11666131204235805 · Cited by 42
Cannabinoids-Promising Antimicrobial Drugs or Intoxicants with Benefits?
Klahn, P. (2020) · Antibiotics · doi:10.3390/antibiotics9060297 · Cited by 43
Sex-dependent differences in the anxiolytic-like effect of cannabidiol in the elevated plus-maze
Fabris, D., de Carvalho, M. C., Brandão, M. L., Prado, W. A., Zuardi, A. W., Crippa, J. A. S., de Oliveira, A. R., Lovick, T. A., & Genaro, K. (2022) · Journal of Psychopharmacology · doi:10.1177/02698811221125440 · Cited by 43
Lack of evidence for the effectiveness or safety of over-the-counter cannabidiol products
Chesney, E., McGuire, P. K., Freeman, T. P., Strang, J., & Englund, A. (2020) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320954992 · Cited by 43
Cannabidiol administration reduces sublesional cancellous bone loss in rats with severe spinal cord injury
De-hao, L., Lin, Z., Meng, Q., Wang, K., Wu, J., & Yan, H. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.05.011 · Cited by 39
Cannabidiol and the Canonical WNT/β-Catenin Pathway in Glaucoma
Vallée, A., Lecarpentier, Y., & Vallée, J.-N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073798 · Cited by 40
Cannabidiol has therapeutic potential for myofascial pain in female and male parkinsonian rats
Vivanco-Estela, A. N., Pereira, M. D. S., Guimarães, F. S., Bel, E. A. D., & Nascimento, G. C. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108700 · Cited by 39
Self-citation
Crosstalk between the M1 muscarinic acetylcholine receptor and the endocannabinoid system: A relevance for Alzheimer's disease?
Thompson, K. J., & Tobin, A. B. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109545 · Cited by 39
THC, CBD, and Anxiety: a Review of Recent Findings on the Anxiolytic and Anxiogenic Effects of Cannabis’ Primary Cannabinoids
Lichenstein, S. D. (2022) · Current Addiction Reports · doi:10.1007/s40429-022-00450-7 · Cited by 38
Cannabidiol regulates behavioural alterations and gene expression changes induced by spontaneous cannabinoid withdrawal
Navarrete, F., Aracil-Fernández, A., & Manzanares, J. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14226 · Cited by 38
Cannabinoid signalling in embryonic and adult neurogenesis: possible implications for psychiatric and neurological disorders
de Oliveira, R. M. W., de Oliveira, C. L., Guimarães, F. S., & Campos, A. C. (2018) · Acta Neuropsychiatrica · doi:10.1017/neu.2018.11 · Cited by 38
Self-citation
Differential contribution of CB1, CB2, 5‐HT1A, and PPAR‐γ receptors to cannabidiol effects on ischemia‐induced emotional and cognitive impairments
Mori, M., Meyer, E., da Silva, F. F., Milani, H., Guimarães, F. S., & de Oliveira, R. M. W. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15134 · Cited by 40
Self-citation
Cannabinoids and Vanilloids in Schizophrenia: Neurophysiological Evidence and Directions for Basic Research
Ruggiero, R. N., Rossignoli, M. T., Ross, J. B. D., Hallak, J. E. C., Leite, J. P., & Bueno-Júnior, L. S. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00399 · Cited by 39
Cannabidiol did not induce teratogenicity or neurotoxicity in exposed zebrafish embryos
Brigante, T. A. V., Abe, F. R., Zuardi, A. W., Hallak, J. E. C., Crippa, J. A. S., & de Oliveira, D. P. (2018) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2018.06.008 · Cited by 37
Natural products as a perspective for cancer pain management: A systematic review
Gouveia, D. N., Guimarães, A. G., Santos, W. B. D. R., & Quintans‐Júnior, L. J. (2018) · Phytomedicine · doi:10.1016/j.phymed.2018.11.026 · Cited by 37
The effects of cannabidiol on worry and anxiety among high trait worriers: a double-blind, randomized placebo controlled trial
Gournay, L. R., Ferretti, M. L., Bilsky, S. A., Vance, E., Nguyen, A., MANN, E. A., Williams, P., & Leen‐Feldner, E. W. (2023) · Psychopharmacology · doi:10.1007/s00213-023-06437-0 · Cited by 41
Could Cannabidiol Be a Treatment for Coronavirus Disease-19-Related Anxiety Disorders?
O’Sullivan, S. E., Stevenson, C. W., & Laviolette, S. R. (2020) · Cannabis and Cannabinoid Research · doi:10.1089/can.2020.0102 · Cited by 37
Adverse Events of Cannabidiol Use in Patients With Epilepsy
Fazlollahi, A., Zahmatyar, M., ZareDini, M., Golabi, B., Nejadghaderi, S. A., Sullman, M. J. M., Gharagozli, K., Kolahi, A., & Safiri, S. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.9126 · Cited by 40
Cannabinoids, interoception, and anxiety
Andrade, A. K., Renda, B., & Murray, J. E. (2019) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2019.03.006 · Cited by 41
Therapeutic Applications of Cannabinoids in Cardiomyopathy and Heart Failure
Garza-Cervantes, J. A., Ramos-González, M. R., Lozano, O., Carlos Jerjes-Sánchez, D., & García‐Rivas, G. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/4587024 · Cited by 38
Female but not male rats show biphasic effects of low doses of Δ9-tetrahydrocannabinol on anxiety: can cannabidiol interfere with these effects?
Salviato, B. Z., Raymundi, A. M., da Silva, T. R., Salemme, B. W., Sohn, J. M. B., de Araujo, F. S., Guimarães, F. S., Bertoglio, L. J., & Stern, C. A. J. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108684 · Cited by 35
Self-citation
Selective post-training time window for memory consolidation interference of cannabidiol into the prefrontal cortex: Reduced dopaminergic modulation and immediate gene expression in limbic circuits
Rossignoli, M. T., Lopes‐Aguiar, C., Ruggiero, R. N., da Silva, R. A. D. V., Bueno-Júnior, L. S., Kandratavicius, L., Peixoto-Santos, J. E., Crippa, J. A. S., Hallak, J. E. C., Zuardi, A. W., et al. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.03.019 · Cited by 34
Possible therapeutic applications of cannabis in the neuropsychopharmacology field
Fernández‐Ruíz, J., Galve‐Roperh, I., Sagredo, O., & Guzmán, M. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.01.013 · Cited by 35
Extrasynaptic Neurotransmission Mediated by Exocytosis and Diffusive Release of Transmitter Substances
Bel, E. A. D., & De‐Miguel, F. F. (2018) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2018.00013 · Cited by 33
Preclinical and Clinical Evidence Supporting Use of Cannabidiol in Psychiatry
Calapai, G., Mannucci, C., Chinou, İ., Cardia, L., Calapai, F., Sorbara, E. E., Firenzuoli, B., Ricca, V., Gensini, G. F., & Firenzuoli, F. (2019) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2019/2509129 · Cited by 36
Cannabidiol Modulates Behavioural and Gene Expression Alterations Induced by Spontaneous Cocaine Withdrawal
Gasparyan, A., Navarrete, F., Rodríguez‐Arias, M., Miñarro, J., & Manzanares, J. (2020) · Neurotherapeutics · doi:10.1007/s13311-020-00976-6 · Cited by 33
Anti-stress neuropharmacological mechanisms and targets for addiction treatment: A translational framework
Greenwald, M. K. (2018) · Neurobiology of Stress · doi:10.1016/j.ynstr.2018.08.003 · Cited by 33
In vitro effects of cannabidiol and its main metabolites in mouse and human Sertoli cells
Li, Y., Wu, Q., Li, X., Tungeln, L. S. V., Beland, F. A., Petibone, D. M., Guo, L., Cournoyer, P., Choudhuri, S., & Chen, S. (2021) · Food and Chemical Toxicology · doi:10.1016/j.fct.2021.112722 · Cited by 32
Contributive Role of TNF-α to L-DOPA-Induced Dyskinesia in a Unilateral 6-OHDA Lesion Model of Parkinson’s Disease
Pereira, M. D. S., de Abreu, G. H. D., Rocca, J., Hamadat, S., Raisman‐Vozari, R., Michel, P. P., & Bel, E. A. D. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.617085 · Cited by 35
Receptome: Interactions between three pain-related receptors or the “Triumvirate” of cannabinoid, opioid and TRPV1 receptors
Zádor, F., & Wollemann, M. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.10.015 · Cited by 30
Subacute cannabidiol alters genome‐wide DNA methylation in adult mouse hippocampus
Flack, N., Colwell, M., Drown, C., & Faulk, C. D. (2020) · Environmental and Molecular Mutagenesis · doi:10.1002/em.22396 · Cited by 31
Sub-chronic treatment with cannabidiol but not with URB597 induced a mild antidepressant-like effect in diabetic rats
Morais, H., Chaves, Y. C., Waltrick, A. P. F., Jesus, C. H. A., Genaro, K., Crippa, J. A. S., da Cunha, J. M., & Zanoveli, J. M. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2018.06.006 · Cited by 32
Targeting the Endocannabinoid System in Psychiatric Illness
Katzman, M. A., Furtado, M., & Anand, L. (2016) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000581 · Cited by 30
The future of type 1 cannabinoid receptor allosteric ligands
Alaverdashvili, M., & Laprairie, R. B. (2018) · Drug Metabolism Reviews · doi:10.1080/03602532.2018.1428341 · Cited by 29
Bones and Joints: The Effects of Cannabinoids on the Skeleton
Ehrenkranz, J. R. L., & Levine, M. A. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00665 · Cited by 31
The epigenetic legacy of illicit drugs: developmental exposures and late-life phenotypes
Flack, N., Colwell, M., & Faulk, C. D. (2019) · Current Zoology · doi:10.1093/eep/dvz022 · Cited by 28
At the intersection of sleep deficiency and opioid use: mechanisms and therapeutic opportunities
Greenwald, M. K., Moses, T. E. H., & Roehrs, T. (2021) · Translational research · doi:10.1016/j.trsl.2021.03.006 · Cited by 29
The endocannabinoid system and related lipids as potential targets for the treatment of migraine‐related pain
Greco, R., Demartini, C., Zanaboni, A. M., Francavilla, M., Icco, R. D., Ahmad, L., & Tassorelli, C. (2022) · Headache The Journal of Head and Face Pain · doi:10.1111/head.14267 · Cited by 45
Assessment of clinical outcomes in patients with post-traumatic stress disorder: analysis from the UK Medical Cannabis Registry
Pillai, M., Erridge, S., Bapir, L., Nicholas, M., Dalavaye, N., Holvey, C., Coomber, R., Barros, D. A. R., Bhoskar, U., Mwimba, G., et al. (2022) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2022.2155139 · Cited by 28
Supraspinal Transient Receptor Potential Subfamily V Member 1 (TRPV1) in Pain and Psychiatric Disorders
Madasu, M. K., Roche, M., & Finn, D. P. (2015) · Modern trends in psychiatry · doi:10.1159/000435934 · Cited by 29
Are CB2 Receptors a New Target for Schizophrenia Treatment?
Cortez, I. L., da Silva, N. R., Guimarães, F. S., & Gomes, F. V. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.587154 · Cited by 29
Self-citation
CBD and the 5-HT1A receptor: A medicinal and pharmacological review
Alexander, C., Jeon, J., Nickerson, K., Hassler, S. N., & Vasefi, M. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.116742 · Cited by 28
Cannabis and intractable chronic pain: an explorative retrospective analysis of Italian cohort of 614 patients
Fanelli, G. C., Carolis, G. D., Leonardi, C., Longobardi, A., Sarli, E., Allegri, M., & Schatman, M. E. (2017) · Journal of Pain Research · doi:10.2147/jpr.s132814 · Cited by 28
Learning and memory is modulated by cannabidiol when administered during trace fear-conditioning
Uhernik, A. L., Montoya, Z. T., Balkissoon, C. D., & Smith, J. P. (2018) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2018.02.009 · Cited by 28
Use of Cannabinoids to Treat Acute Respiratory Distress Syndrome and Cytokine Storm Associated with Coronavirus Disease-2019
Nagarkatti, P. S., Miranda, K., & Nagarkatti, M. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.589438 · Cited by 29
Subclinical Depressive Symptoms and Continued Cannabis Use: Predictors of Negative Outcomes in First Episode Psychosis
González–Ortega, I., Alberich, S., Echeburúa, E., Aizpuru, F., Millán, E., Vieta, E., Matute, C., & González-Pinto, A. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0123707 · Cited by 28
Canabinoides ajudam a desvendar aspectos etiológicos em comum e trazem esperança para o tratamento de autismo e epilepsia
Malcher‐Lopes, R. (2014) · Revista da Biologia · doi:10.7594/revbio.13.01.07 · Cited by 29
Hippocampal mammalian target of rapamycin is implicated in stress-coping behavior induced by cannabidiol in the forced swim test
Sartim, A. G., Sales, A. J., Guimarães, F. S., & Joca, S. R. L. (2018) · Journal of Psychopharmacology · doi:10.1177/0269881118784877 · Cited by 29
Self-citation
Potential Role of Cannabidiol on Sports Recovery: A Narrative Review
Rojas‐Valverde, D. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.722550 · Cited by 32
Medial prefrontal cortex mechanisms of cannabidiol-induced aversive memory reconsolidation impairments
Bayer, H., Stern, C. A. J., Troyner, F., Gazarini, L., Guimarães, F. S., & Bertoglio, L. J. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108913 · Cited by 29
Self-citation
Cannabidiol attenuates fear memory expression in female rats via hippocampal 5-HT1A but not CB1 or CB2 receptors
Franzen, J. M., Werle, I., Vanz, F., de Oliveira, B. B., Nascimento, L. M. M., Guimarães, F. S., & Bertoglio, L. J. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109316 · Cited by 27
Self-citation
Neuromotor tolerability and behavioural characterisation of cannabidiolic acid, a phytocannabinoid with therapeutic potential for anticipatory nausea
Brierley, D. I., Samuels, J., Duncan, M., Whalley, B. J., & Williams, C. M. (2015) · Psychopharmacology · doi:10.1007/s00213-015-4100-1 · Cited by 27
The Anxiolytic Effects of Cannabidiol (CBD)
Zuardi, A. W., Crippa, J. A. S., Hallak, J. E. C., Campos, A. C., & Guimarães, F. S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-800756-3.00097-1 · Cited by 29
Self-citation
Acute and Extended Anxiolytic Effects of Cannabidiol in Cannabis Flower: A Quasi-Experimental ad libitum Use Study
Bidwell, L. C., Martin‐Willett, R., Skrzynski, C. J., Lisano, J. K., Torres, M. O., Giordano, G., Hutchison, K. E., & Bryan, A. D. (2024) · Cannabis and Cannabinoid Research · doi:10.1089/can.2023.0187 · Cited by 26
Effects of Cannabidiol on Diabetes Outcomes and Chronic Cerebral Hypoperfusion Comorbidities in Middle-Aged Rats
Santiago, A. N., Mori, M., Guimarães, F. S., Milani, H., & de Oliveira, R. M. W. (2018) · Neurotoxicity Research · doi:10.1007/s12640-018-9972-5 · Cited by 26
Self-citation
Early-life stress induces emotional and molecular alterations in female mice that are partially reversed by cannabidiol
Martín‐Sánchez, A., González‐Pardo, H., Alegre-Zurano, L., Castro‐Zavala, A., López-Taboada, I., Valverde, O., & Conejo, N. M. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2021.110508 · Cited by 25
Cannabinol modulates neuroprotection and intraocular pressure: A potential multi-target therapeutic intervention for glaucoma
Somvanshi, R. K., Zou, S., Kadhim, S., Padania, S., Hsu, E., & Kumar, U. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2021.166325 · Cited by 25
Development of an In Vitro Release Assay for Low-Density Cannabidiol Nanoparticles Prepared by Flash NanoPrecipitation
Caggiano, N. J., Wilson, B. K., Priestley, R. D., & Prud’homme, R. K. (2022) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.2c00041 · Cited by 25
Pharmacists and the future of cannabis medicine
Schmitz, N. S., & Richert, L. (2019) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2019.11.007 · Cited by 24
Determination of cannabinoids in hemp oil based cosmetic products by LC-tandem MS
Hsu, Y.-H., Fang, M., Huang, S.-C., Kao, Y., Tseng, S.-H., & Wang, D. (2021) · Journal of Food and Drug Analysis · doi:10.38212/2224-6614.3370 · Cited by 24
Effects of Δ9-Tetrahydrocannibinol (THC) on Obesity at Different Stages of Life: A Literature Review
Fearby, N. L., Penman, S. L., & Thanos, P. K. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19063174 · Cited by 27

Authors: Campos, A. C., Moreira, F. A., Gomes, F. V., Del Bel, E. A., & Guimarães, F. S.
Affiliations: Universidade Federal de Minas Gerais (BR)
Department of Pharmacology, Institute of Biological Sciences, Universidade Federal de Minas Gerais, Avenue Antonio Carlos 6627, 31270-901, Belo Horizonte, Minas Gerais, Brazil
Universidade de São Paulo (BR)
Faculty of Odontology of Ribeirão Preto, Department of Morphology, Physiology and Stomatology, University of São Paulo, Avenue Café s/n, 14040-904, Ribeirão Preto, São Paulo, Brazil
ORCID: Campos, Alline Cristina
Guimarães, Francisco Silveira
Venue: Philosophical Transactions of the Royal Society B: Biological Sciences
Publisher: The Royal Society
Published: 2012-12-05
Volume: 367
Issue: 1607
Pages: 3364-3378
ISSN: 0962-8436 (ISSN-L)
1471-2970
DOI: 10.1098/rstb.2011.0389
PMC: PMC3481531
OpenAlex: W2108265345
Cited by: 475
References: 135
Citations by year: 2026: 21 · 2025: 27 · 2024: 42 · 2023: 39 · 2022: 53 · 2021: 51 · 2020: 50 · 2019: 39 · 2018: 36 · 2017: 35 · 2016: 33 · 2015: 24 · 2014: 15 · 2013: 6 · 2012: 2
FWCI: 1.72
Type: journal article
Language: en
Open access: green
europepmc.org
Licence: royalsociety.org/journals/ethics-policies/data-sharing-mining/ (tdm)
Locations: Philosophical Transactions of the Royal Society B Biological Sciences (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plant Extracts Effects
Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
Keywords: cannabidiol, phytocannabinoids, anxiety, depression, psychosis, anxiolytic effects, antidepressant-like effects, 5-HT1A receptor, bed nucleus of the stria terminalis, medial prefrontal cortex, anandamide, TRPV1 channel, antipsychotic effects, bell-shaped dose-response, extinction, memory reconsolidation, adult hippocampal neurogenesis, CB1 receptor antagonism, CB2 receptor, GPR55, PPARγ
MeSH terms: Animals, Antidepressive Agents, Anxiety Disorders, Arachidonic Acids, Cannabidiol, Clinical Trials as Topic, Depression, Dose-Response Relationship, Drug, Humans, Phytotherapy, Synaptic Transmission, Psychotic Disorders, Anti-Anxiety Agents, Receptor, Cannabinoid, CB1, Receptor, Serotonin, 5-HT1A, TRPV Cation Channels, Polyunsaturated Alkamides, Neurogenesis, Endocannabinoids

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks